{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:53:54Z","timestamp":1777704834693,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10875-023-01549-w","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:01:56Z","timestamp":1689379316000},"page":"1812-1826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcome of Second Allogeneic HSCT for Patients with Inborn Errors of Immunity: Retrospective Study of 20 Years\u2019 Experience"],"prefix":"10.1007","volume":"43","author":[{"given":"Priti","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1368-104X","authenticated-orcid":false,"given":"Christo","family":"Tsilifis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Han","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleri","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Nademi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"issue":"1","key":"1549_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-022-01289-3","volume":"40","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;40(1):24\u201364. https:\/\/doi.org\/10.1007\/s10875-022-01289-3.","journal-title":"J Clin Immunol"},{"key":"1549_CR2","doi-asserted-by":"publisher","unstructured":"Lankester AC, Albert MH, Booth C, Gennery AR, G\u00fcng\u00f6r T, H\u00f6nig M, et al. EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021;(March). https:\/\/doi.org\/10.1038\/s41409-021-01378-8.","DOI":"10.1038\/s41409-021-01378-8"},{"issue":"14","key":"1549_CR3","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1182\/blood.2022015506","volume":"140","author":"MH Albert","year":"2022","unstructured":"Albert MH, Sirait T, Eikema DJ, Bakunina K, Wehr C, Suarez F, et al. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood. 2022;140(14):1635\u201349.","journal-title":"Blood"},{"issue":"2","key":"1549_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","volume":"57","author":"ZN Ozdemir","year":"2018","unstructured":"Ozdemir ZN, Civriz BS. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfus Apher Sci. 2018;57(2):163\u20137.","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"1549_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/bmt.2012.239","volume":"48","author":"R Olsson","year":"2013","unstructured":"Olsson R, Remberger M, Schaffer M, Berggren DM, Svahn B-M, Mattsson J, et al. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48(4):537\u201343. https:\/\/www.nature.com\/articles\/bmt2012239. Accessed 1 Mar 2023","journal-title":"Bone Marrow Transplant"},{"key":"1549_CR6","doi-asserted-by":"publisher","unstructured":"Forlanini F, Chan A, Dara J, Dvorak CC, Cowan MJ, Puck JM, et al. Impact of genetic diagnosis on the outcome of hematopoietic stem cell transplant in primary immunodeficiency disorders. J Clin Immunol. 2022;(0123456789). https:\/\/doi.org\/10.1007\/s10875-022-01403-5.","DOI":"10.1007\/s10875-022-01403-5"},{"issue":"1","key":"1549_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/16078454.2022.2042064","volume":"27","author":"J Chen","year":"2022","unstructured":"Chen J, Pang A, Zhao Y, Liu L, Ma R, Wei J, et al. Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes. Hematology. 2022;27(1):293\u20139. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35192779. Accessed 1 Mar 2023","journal-title":"Hematology"},{"key":"1549_CR8","doi-asserted-by":"publisher","unstructured":"Tsilifis C, Lum SH, Nademi Z, Hambleton S, Flood TJ, Williams EJ, et al. TCR\u03b1\u03b2-depleted haploidentical grafts are a safe alternative to HLA-matched unrelated donor stem cell transplants for infants with severe combined immunodeficiency. J Clin Immunol. 2022;(0123456789). https:\/\/doi.org\/10.1007\/s10875-022-01239-z.","DOI":"10.1007\/s10875-022-01239-z"},{"issue":"13","key":"1549_CR9","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1182\/blood.2021014687","volume":"139","author":"MH Albert","year":"2022","unstructured":"Albert MH, Slatter MA, Gennery AR, G\u00fcng\u00f6r T, Bakunina K, Markovitch B, et al. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. Blood. 2022;139(13):2066\u201379.","journal-title":"Blood"},{"issue":"10","key":"1549_CR10","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","volume":"136","author":"R Chiesa","year":"2020","unstructured":"Chiesa R, Wang J, Blok HJ, Hazelaar S, Neven B, Moshous D, et al. Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood. 2020;136(10):1201\u201311.","journal-title":"Blood"},{"issue":"3","key":"1549_CR11","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.bbmt.2019.12.083","volume":"26","author":"MS Thakar","year":"2020","unstructured":"Thakar MS, Logan B, Buckley RH, Haddad E, Dvorak CC, O\u2019Reilly RJ, et al. Transplantation outcomes for children with severe combined immune deficiency (SCID) have improved over time: a 36-year summary report by the Primary Immune Deficiency Treatment Consortium (PIDTC). Biol Blood Marrow Transplant. 2020;26(3):S18\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1549_CR12","doi-asserted-by":"crossref","unstructured":"Valc\u00e1rcel D, Sureda A. Chapter 41: Graft failure. In: The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th ed. 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553978\/. Accessed 1 Mar 2023","DOI":"10.1007\/978-3-030-02278-5_93"},{"key":"1549_CR13","doi-asserted-by":"crossref","unstructured":"Holler E, Greinix H, Zeiser R. Acute graft-versus-host disease. In: Carreras E, Dufour C, Mohty M, Kr\u00f6ger N, editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies [Internet]. 7th ed. Chapter 43. Cham (CH): Springer; 2019.","DOI":"10.1007\/978-3-030-02278-5_43"},{"issue":"11","key":"1549_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53(11):1401\u201315.","journal-title":"Bone Marrow Transplant"},{"issue":"Supplement 1","key":"1549_CR15","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1182\/blood-2018-99-119792","volume":"132","author":"R Elkeky","year":"2018","unstructured":"Elkeky R, Jacobsohn DA, Agarwal R, Naik S, Kapoor N, Krishnamurti L, et al. Administration of rimiducid following haploidentical BPX-501 cells in children with malignant or non-malignant disorders who develop graft-versus-host-disease (GvHD). Blood. 2018;132(Supplement 1):2207. https:\/\/doi.org\/10.1182\/blood-2018-99-119792.","journal-title":"Blood"},{"issue":"1","key":"1549_CR16","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1111\/j.1399-0012.2010.01324.x","volume":"25","author":"M Remberger","year":"2011","unstructured":"Remberger M, Mattsson J, Olsson R, Ringd\u00e9n O. Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure. Clin Transplant. 2011;25(1):E68-76.","journal-title":"Clin Transplant"},{"issue":"20","key":"1549_CR17","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood.2019001757","volume":"134","author":"A Laberko","year":"2019","unstructured":"Laberko A, Sultanova E, Gutovskaya E, Shipitsina I, Shelikhova L, Kurnikova E, et al. Mismatched related vs matched unrelated donors in TCR\u03b1\u03b2\/CD19-depleted HSCT for primary immunodeficiencies. Blood. 2019;134(20):1755\u201363. https:\/\/doi.org\/10.1182\/blood.2019001757.","journal-title":"Blood"},{"key":"1549_CR18","doi-asserted-by":"publisher","unstructured":"Ramanathan S, Lum SH, Nademi Z, Carruthers K, Watson H, Flood T, et al. CD3+TCR\u03b1\u03b2\/CD19+ depleted mismatched family or unrelated donor salvage stem cell transplantation for graft dysfunction in inborn errors of immunity. Transplant Cell Ther. 2023. https:\/\/doi.org\/10.1016\/j.jtct.2023.05.019.","DOI":"10.1016\/j.jtct.2023.05.019"},{"key":"1549_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41409-020-01152-2","volume":"3","author":"SH Lum","year":"2020","unstructured":"Lum SH, Sobh A, Carruthers K, Nademi Z, Watson H, McNaughton P, et al. Improved survival and graft function in ex vivo T-cell depleted haploidentical hematopoietic cell transplantation for primary immunodeficiency. Bone Marrow Transplant. 2020;3:4\u20138. https:\/\/doi.org\/10.1038\/s41409-020-01152-2.","journal-title":"Bone Marrow Transplant"},{"key":"1549_CR20","doi-asserted-by":"crossref","unstructured":"Laberko A, Sultanova E, Idarmacheva A, Skvortsova Y, Shelikhova L, Nechesnyuk A, et al. Second allogeneic hematopoietic stem cell transplantation in patients with inborn errors of immunity. Bone Marrow Transplant. 2022;(August):1\u20139.","DOI":"10.1038\/s41409-022-01883-4"},{"issue":"10","key":"1549_CR21","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.bbmt.2020.07.003","volume":"26","author":"JF Fernandes","year":"2020","unstructured":"Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, et al. Outcomes after haploidentical stem cell transplantation with post-transplantation cyclophosphamide in patients with primary immunodeficiency diseases. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2020;26(10):1923\u20139.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"10","key":"1549_CR22","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/bmt.2015.153","volume":"50","author":"K Kudo","year":"2015","unstructured":"Kudo K, Muramatsu H, Yoshida N, Kobayashi R, Yabe H, Tabuchi K, et al. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia. Bone Marrow Transplant. 2015;50(10):1312\u20135.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"1549_CR23","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jaci.2021.10.017","volume":"149","author":"AC Lankester","year":"2022","unstructured":"Lankester AC, Neven B, Mahlaoui N, von Asmuth EGJ, Courteille V, Alligon M, et al. Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006\u20132014 European cohort. J Allergy Clin Immunol. 2022;149(5):1744-1754.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1549_CR24","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","volume":"96","author":"PD Kottaridis","year":"2000","unstructured":"Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S, et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood. 2000;96(7):2419\u201325.","journal-title":"Blood"},{"issue":"11","key":"1549_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/ajh.24141","volume":"90","author":"H Abdel-Azim","year":"2015","unstructured":"Abdel-Azim H, Mahadeo KM, Zhao Q, Khazal S, Kohn DB, Crooks GM, et al. Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: an alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. Am J Hematol [Internet]. 2015;90(11):1021\u20136. https:\/\/doi.org\/10.1002\/ajh.24141.","journal-title":"Am J Hematol [Internet]"},{"issue":"3","key":"1549_CR26","first-page":"233","volume":"13","author":"SR McCann","year":"1994","unstructured":"McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P, et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant. 1994;13(3):233\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"1549_CR27","doi-asserted-by":"crossref","unstructured":"Devine SM, Bo-Subait S, Kuxhausen M, Spellman SR, Bupp C, Ahn KW, et al. Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic. Blood Adv. 2023. https:\/\/ashpublications.org\/bloodadvances\/article\/doi\/10.1182\/bloodadvances.2023009786\/495268\/Clinical-Impact-of-Cryopreservation-of-Allogeneic. Accessed 1 Mar 2023","DOI":"10.1182\/bloodadvances.2023009786"},{"issue":"5","key":"1549_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s12185-010-0714-6","volume":"92","author":"M Sumi","year":"2010","unstructured":"Sumi M, Shimizu I, Sato K, Ueki T, Akahane D, Ueno M, et al. Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation. Int J Hematol. 2010;92(5):744\u201350.","journal-title":"Int J Hematol"},{"issue":"10","key":"1549_CR29","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.bbmt.2009.06.011","volume":"15","author":"B Gyurkocza","year":"2009","unstructured":"Gyurkocza B, Cao TM, Storb RF, Lange T, Leisenring W, Franke GN, et al. Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2009;15(10):1314\u201322.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01549-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01549-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01549-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:29:22Z","timestamp":1700476162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01549-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1549"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01549-w","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (retrospective data collection only).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent for participation in retrospective studies was obtained from all individual participants or their parents, in line with institutional policy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed consent for participation in retrospective studies was obtained from all individual participants or their parents, in line with institutional policy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}